2023 - Research.com Immunology in Israel Leader Award
His primary scientific interests are in Pediatrics, Vaccination, Immunology, Virology and Incidence. His studies deal with areas such as Surgery, Epidemiology, Cohort study, Rubella and Etiology as well as Pediatrics. His Vaccination research is multidisciplinary, relying on both Internal medicine and Confidence interval.
His research brings together the fields of Meningococcal disease and Immunology. His Virology research incorporates elements of Carriage, Seroprevalence and Young adult. His biological study spans a wide range of topics, including Influenza A virus and Pandemic.
Nick Andrews mostly deals with Vaccination, Pediatrics, Immunology, Virology and Epidemiology. His research integrates issues of Internal medicine, Confidence interval and Immunization in his study of Vaccination. His research in Pediatrics intersects with topics in Incidence, Measles, Pneumococcal conjugate vaccine, Disease and Public health.
His Public health course of study focuses on Cohort and Cohort study. As a part of the same scientific study, Nick Andrews usually deals with the Immunology, concentrating on Meningococcal disease and frequently concerns with Meningococcal vaccine and Tetanus. His work investigates the relationship between Epidemiology and topics such as Outbreak that intersect with problems in Environmental health.
His primary areas of study are Public health, Vaccination, Pediatrics, Internal medicine and Epidemiology. The Public health study combines topics in areas such as Incidence, Severe acute respiratory syndrome coronavirus 2, Asymptomatic, Pandemic and Cohort. The study incorporates disciplines such as Pertussis vaccine, Titer and Confidence interval in addition to Vaccination.
Nick Andrews performs multidisciplinary studies into Pediatrics and Booster in his work. His Internal medicine study incorporates themes from Coinfection and Meningococcal vaccine. The Epidemiology study which covers Disease that intersects with Group B.
Nick Andrews mainly focuses on Public health, Internal medicine, Pandemic, Pediatrics and Vaccination. Nick Andrews combines subjects such as Intensive care medicine, Cohort, Family medicine and Medical emergency with his study of Public health. His studies examine the connections between Internal medicine and genetics, as well as such issues in Influenza vaccine, with regards to Influenza a and Primary care.
His Pediatrics study combines topics from a wide range of disciplines, such as Epidemiology and Disease. His Epidemiology research incorporates themes from Meningitis and Incidence. The concepts of his Vaccination study are interwoven with issues in Rotavirus vaccine, Intussusception, Increased risk and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher.
The New England Journal of Medicine (2021)
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
Elizabeth Miller;Katja Hoschler;Pia Hardelid;Elaine Stanford.
The Lancet (2010)
Effectiveness of maternal pertussis vaccination in England: an observational study
Gayatri Amirthalingam;Nick Andrews;Helen Campbell;Sonia Ribeiro.
The Lancet (2014)
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Elizabeth Miller;Nicholas J Andrews;Pauline A Waight;Mary P E Slack.
Lancet Infectious Diseases (2011)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.
Caroline L Trotter;Nick J Andrews;Edward B Kaczmarski;Elizabeth Miller.
The Lancet (2004)
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson.
Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
Wendy A. Knowles;Pam Pipkin;Nick Andrews;Andrew Vyse.
Journal of Medical Virology (2003)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Pauline A Waight;Nicholas J Andrews;Shamez N Ladhani;Carmen L Sheppard.
Lancet Infectious Diseases (2015)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
Mary E Ramsay;Nick J Andrews;Caroline L Trotter;Edward B Kaczmarski.
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
Martin C. J. Maiden;Ana Belén Ibarz-Pavón;Rachel Urwin;Stephen J. Gray.
The Journal of Infectious Diseases (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: